Vyome Holdings Inc. (HIND): Qarzning balans kapitallashuviga nisbati
Vyome Holdings Inc (HIND) teri patologiyalarini davolash uchun innovatsion immunologik agentlarni ishlab chiqmoqda. Qarzning kapitalga nisbati leveraj dinamikasini aks ettiradi va ushbu ko'rsatkich 0.00 darajasida turibdi. Biznesning barqarorligi patent himoyasi va klinik sinovlar natijalari bilan ta'minlanmoqda, inson kapitali esa semizlik va immunologiya sohasidagi ekspertlarning ishga jalb etilishi bilan mustahkamlanmoqda.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_HIND_-_Vyome-Holdings-Inc_-_Debt-to-Net-Assets-Ratio "HIND: Vyome Holdings Inc Qarzning balans kapitallashuviga nisbati 16.08.2025 - 31.10.2026 | 👁️GURU.Markets👁️")
Vyome Holdings Inc. (HIND) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Vyome Holdings Inc|HIND - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati ReShape Lifesciences|HIND - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Vyome Therapeutics|HIND - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Vyome Holdings|Tezkor likvidlik ko‘rsatkichi reshapelifesciences.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:HIND (Vyome Holdings Inc)
Vyome Holdings Inc (HIND) yuqori xavfli immunologik dori vositalarini ishlab chiqish sektorida raqobatlashmoqda. Qarzning kitob qiymatiga nisbati kompaniyaning klinik sinovlarni o'tkazish uchun tashqi moliyalashtirishga bo'lgan bog'liqligini miqdoriy tarzda belgilaydi. Ushbu koeffitsient kapital tuzilmasidagi qarz mablag'larining ulushini o'lchaydi. Ushbu ko'rsatkichning pasayishi moliyaviy avtonomiyani tasdiqlaydi, holbuki uning oshishi qarz yukining ortishidan dalolat beradi. Kompaniyaning balans hisobotidagi moliyaviy leverajini tahlil qilish orqali investor biznesning investitsiya xavflariga chidamliligini baholaydi.
Vyome Holdings Inc (HIND) raqobatchilari
Balans kapitallashuviga qarzlar ARGX (argenx SE)|Balans kapitallashuviga qarzlar biontech.de BNTX|ABVX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ADMA (ADMA Biologics Inc)|Protagonist Therapeutics Inc (PTGX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Immunovant Therapeutics|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com|Qarzning balans qiymatiga nisbati ADPT (Adaptive Biotechnologies Corporation)|CLDX (Celldex Therapeutics Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AUPH (Aurinia Pharma)|Sof aktivlarga qarzlar BioCryst Corp (BCRX)|VERA - Qarzning balans kapitallashuviga nisbati|dianthustx.com (DNTH) - Qarzning balans qiymatiga nisbati|Pharvaris (PHVS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|Qarzning balans qiymatiga nisbati TRML|Balans kapitallashuviga qarzlar Precigen Corp|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. (PHAR)|nektar.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar UPB (Upstream Bio)|Zenas Bio (ZBIO) - Balans qiymatiga qarzlar|IMNM: Qarzning balans qiymatiga nisbati|GOSS: Qarzning balans kapitallashuviga nisbati|KALV (KalVista Pharmaceuticals) - Qarzning balans qiymatiga nisbati|Balans qiymatiga qarzlar septerna.com (SEPN)|Qarzning balans kapitallashuviga nisbati Pieris Pharmaceuticals, Inc.|Balans qiymatiga qarzlar Savara Inc SVRA|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc (RIGL)|Qarzning balans qiymatiga nisbati AnaptysBio Inc. ANAB|Balans kapitallashuviga qarzlar ATXS (Astria Therapeutics)|engene.com (ENGN) - Balans qiymatiga qarzlar|RAPT: Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati JBIO (Aerovate Therapeutics Inc)|ACRS: Balans kapitallashuviga qarzlar|Kyverna Therapeutics, Inc - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Tiziana Life Sciences|Balans qiymatiga qarzlar cabalettabio.com CABA|Qarzning balans kapitallashuviga nisbati Ventyx Biosciences, Inc. (VTYX)|Qarzning balans kapitallashuviga nisbati THTX (Theratechnologies, Inc.)|Balans kapitallashuviga qarzlar AVTX (Avalo Therapeutics Inc.)|ELDN: Qarzning balans qiymatiga nisbati|Agenus - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar climbbio.com CLYM|Zura Bio Limited (ZURA) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ATYR|ADAG (Adagene Inc) - Balans kapitallashuviga qarzlar|IMA - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Shattuck Labs, Inc. (STTK)|Sof aktivlarga qarzlar equilliumbio.com|Connect Biopharma Holdings Limited - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati IMUX|Atara Biotherapeutics Inc - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar InflaRx N.V. IFRX|X4 Pharmaceuticals (XFOR) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ACET|CELU (Celularity Inc) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati INmune Bio Inc (INMB)|Balans kapitallashuviga qarzlar BRNS|KZR (Kezar Life Sciences Inc) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SABS (SAB Biotherapeutics)|Sof aktivlarga qarzlar akaritx.com (AKTX)|ENLV - Qarzning balans kapitallashuviga nisbati|QTTB (Q32 Bio Inc.) - Qarzning balans qiymatiga nisbati|GOVX: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati EDSA|Qarzning balans kapitallashuviga nisbati iBio, Inc.|Carisma Tx - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar XTLB|BOLT (boltbio.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar HCWB (HCW Biologics)|Balans kapitallashuviga qarzlar Aptevo Therapeutics, Inc. APVO|AIM - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ADTX (Aditxt)|GRI Bio (GRI) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati XORTX Therapeutics Inc|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Indaptus Corp|Qarzning balans qiymatiga nisbati SCNI (Scinai Immunotherapeutics)|CALI (calcimedica.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AFMD (Affimed N.V.)|Sof aktivlarga qarzlar Allakos Inc (ALLK)|HOOK - Qarzning balans kapitallashuviga nisbati|IGM Biosciences, Inc. (IGMS) - Qarzning balans qiymatiga nisbati|iTeos Therapeutics (ITOS) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati oceanbiomedical.com|Qarzning balans qiymatiga nisbati TCBP|Balans kapitallashuviga qarzlar Third Harmonic Bio Inc.